← Back to Search

Other

Intranasal capsaicin for Non-Allergic Rhinitis

Phase 3
Recruiting
Led By Kunal R Shetty, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks post treatment, 12 weeks post treatment
Awards & highlights

Study Summary

This trial studied how people with non-allergic rhinitis respond to capsaicin treatment and if IgE levels change.

Eligible Conditions
  • Non-Allergic Rhinitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks post treatment, 12 weeks post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks post treatment, 12 weeks post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in maximum optical density determined via optical rhinometry
Change in nasal itching as measured by the visual analog scale (VAS)
Change in nasal obstruction as measured by the visual analog scale (VAS)
+2 more
Secondary outcome measures
Change in local IgE level

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,944 Total Patients Enrolled
American Academy of Otolaryngic Allergy & FoundationUNKNOWN
1 Previous Clinical Trials
36 Total Patients Enrolled
Kunal R Shetty, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population
Kunal R. Shetty 2019. "The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05093478.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top